IBRX is trading 3.3% up today at $7.46 as investors digest the May 26, 2026, lead-plaintiff filing deadline for ongoing securities class actions.
- The stock is rebounding from earlier pressure following allegations of misleading statements regarding Anktiva and related class-action filings.
- With no fresh operating updates released this morning, the move is likely influenced by the legal-headline overhang and a generally supportive broader market backdrop.